AbbVie
ABBV
#26
Rank
HK$3.109 T
Marketcap
HK$1,759
Share price
-1.15%
Change (1 day)
31.87%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of September 2025 : -HK$20.23 Billion

According to AbbVie's latest financial reports the company has -HK$20.23 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$HK$26.11 B-67.84%
2023-12-31$HK$81.20 B-39.88%
2022-12-31$HK$135.06 B12.22%
2021-12-31$HK$120.36 B18.55%
2020-12-31$HK$101.53 B-259.53%
2019-12-31$-HK$63.65 Billion-3.77%
2018-12-31$-HK$66.14 Billion-266.09%
2017-12-31$HK$39.82 B10.77%
2016-12-31$HK$35.95 B17.57%
2015-12-31$HK$30.57 B126.3%
2014-12-31$HK$13.51 B-61.21%
2013-12-31$HK$34.83 B33.63%
2012-12-31$HK$26.06 B-71.87%
2011-12-31$HK$92.67 B-24.16%
2010-12-31$HK$122.20 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
HK$724.45 B-3,681.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$144.74 B-815.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$185.60 B-1,017.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$74.85 B-470.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$166.96 B-925.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$141.68 B-800.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$164.78 B-914.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
HK$357.73 B-1,868.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$23.37 B-215.57%๐Ÿ‡บ๐Ÿ‡ธ USA